Pathogenesis of decreased glucose turnover and oxidative phosphorylation in ischemic and trauma-induced dementia of the Alzheimer type

Annals of the New York Academy of Sciences

Volumn 826, Issue , 1997, Pages 229-241

  Meier Ruge, W A ^a   Bertoni Freddari, C ^b  

^a University Medical School   (Switzerland)

^b INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CALCIUM CHANNEL; CALCIUM ION; CARBON 14; FLUORODEOXYGLUCOSE F 18; GLUCOSE; GLUTAMIC ACID; NEUROTROPIC AGENT;

AMINO ACID TRANSPORT; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN METABOLISM; BRAIN MITOCHONDRION; CONFERENCE PAPER; DEMENTIA; ENZYME INACTIVATION; GLUCOSE METABOLISM; HUMAN; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PATHOGENESIS; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSITRON; PROTEIN PROCESSING;

EID: 0030708717     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb48474.x     Document Type: Conference Paper

References (71)

1. ABE, K., P. H. GEORGE-HYSLOP, R. E. TANZI & K. KOGURE. 1991. Induction of amyloid precursor protein in RNA after heat shock in cultured human lymphoblast cells. Neurosci. Lett. 125: 169-171.
2. ABE, K., R. E. TANZI & K. KOGURE. 1991. Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex. Neurosci. Lett. 125: 172-174.
3. BARGER, S. W., V. L. SMITH-SWINTOSKY, R. E. RYDEL & M. P. MATTSON. 1993. Beta-amyloid precursor protein mismetabolism and loss of calcium homeostasis in Alzheimer's disease. Ann. N. Y. Acad. Sci. 695: 158-164.
4. BEAL, M. F. 1992. Does impairment of energy metabolism result in excitotoxic neuronal death in neuodegenerative illness? Ann. Neurol. 31: 119-130.
5. BEAL, M. F. 1994. Energy, oxidative damage, and Alzheimer's disease: Clues to the underlying puzzle. Neurobiol. Aging 15(Suppl. 2): 171-174.
6. BERTONI-FREDDARI, C., P. FATTORETTI, T. CASOLI, W. MEIER-RUGE & J. ULRICH. 1991. Reactive capacities of the central nervous system in physiological aging and senile dementia of the Alzheimer type. Ann. N. Y. Acad. Sci. 621: 98-103.
7. BERTONI-FREDDARI, C. P. FATTORETTI, T. CASOLI, C. SPAGNA, W. MEIER-RUGE & J. ULRICH. 1993. Morphological plasticity of synaptic mitochondria during aging. Brain Res. 628: 193-200.
8. BERTONI-FREDDARI, C. P. FATTORETTI, R. PAOLINI, U. CASELLI, L. GALEAZZI & W. MEIER-RUGE. 1996. Synaptic structural dynamics and aging. Gerontology 42: 170-180.
9. BERTONI-FREDDARI, C., P. FATTORETTI, M. PIERONI, W. MEIER-Ruge & J. ULRICH. 1992. Enlargement of synaptic size as a compensative reaction in aging and dementia. Path. Res. Pract. 188: 612-615.
10. BIGL, M. & K. ESCHIERICH. 1995. Interaction of rat brain phosphofructokinase with Alzheimer's beta A4-amyloid. Neurochem. Internat. 26: 69-75.
11. BLASS, J. P., A. C. BAKER, L. W. Ko & R. S. BLACK. 1990. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch. Neurol. 47: 864-869.
12. BLASS, J. P. & G. E. GIBSON. 1991. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev. Neurol. (Paris) 147: 512-525.
13. BROWN, M. D. & D. C. WALLACE. 1994. Molecular basis of mitochondrial DNA disease. J. Bioenerg. Biomembr. 26: 273-289.
14. BROWNE, S. E. & M. F. BEAL. 1994. Oxidative damage and mitochondrial dysfunction in neurodegenerative diseases. Biochem. Soc. Trans. 22: 1002-1006.
15. CRAFT, S., J. NEWCOMER, S. KANNE, S. DAGOGO-JACK., P. CRYER, Y. SHELINE, J. LUBY, A. DAGOGO-JACK & A. ALDERSON. 1996. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging 17: 123-130.
16. DECARLI, C., C. L. GRADY, C. M. CLARK, D. A. KATZ, D. R. BRADY, D. G. M. MURPHY, J. V. HAXBY, J. A. SALERNO, J. A. GILETTO, A. GONALEZ-AVILES & S. J. RAPOPORT, 1996. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J. Neurol. Neurosurg. Psychiatry 60: 158-167.
17. DODO. P. R., J. L. SOTT & R. J. WESTPHALEN. 1994. Excitotoxic mechanisms in the pathogenesis of dementia. Neurochem. Internat. 25: 203-219.
18. ERECINSKA, M. & I. A. SILVER. 1989. ATP and brain functions. J. Cerebr. Blood Flow Metab. 9: 2-19.
19. FATTORETTI, P., C. BERTONI-FREDDARI, U. CASELLI, R. PAOLONI & W. MEIER-RUGE. 1996. Morphological changes in cerebellar mitochondria during aging. Anal. Quant. Histol. 18: 205-208.
20. FLEMING, J. E., J. MIOUEL, S. F. COTTRELL, L. S. YENGOYAN & A. C. ECONOMOS. 1982. Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontology 28: 44-53.
21. FUKUYAMA, H., M. OGAWA, H., YAMAUCHI, S. YAMAGUCHI, J. KIMURA, Y. VONEKURA & J. KONISCHI. 1994. Altered cerebral metabolism in Alzheimer's disease: A PET study. J. Nucl. Med. 35: 24-26.
22. GABUZDA, D. H., J. BUGICIGLIO, L. B. CHEN, P. MATSUDAIRA & B. A. YANKNER. 1994. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269: 13623-13628.
23. GSELL, W., R. CONRAD, M. HICKETHIER, E. SOFIE., L. FRÖHLICH, J. WICHARD, K. JELLINGER, G. MOLL, G. RANSMAYER, H. BECKMANN & P. RIEDERER. 1995. Decreased catalase activity but unchanged Superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J. Neurochem. 64: 1216-1223.
24. HARMAN, D. 1993. Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer's type. Age 16: 23-30.
25. HENNEBERG, N. & S. HOVER. 1995. Desensitization of the neuronal insulin receptor: A new approach in the etiopathogenesis of late-onset sporadic dementia of the Alzheimer type (SDAT)? Arch. Gerontol. Geriatr. 21: 63-74.
26. HENNEBERRY, R. C. 1989. The role of neuronal energy in the neurotoxicity of excitatory amino acids. Neurobiol. Aging 10: 611-612.
27. HOYER, S. 1994. Age as risk factor for sporadic dementia of the Alzheimer type? Ann. N. Y. Acad. Sci. 719: 248-256.
28. HOYER, S. 1996. Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Acta Neurol. Scand. 93(Suppl 165): 18-24.
29. ISHIURA, S. 1991. Proteolytic clearage of the Alzheimer's disease amyloid A4 precursor protein. J. Neurochem. 56: 363-369.
30. IWANGOFF, P., R. ARMBRUSTER, A. ENZ & W. MEIER-RUGE. 1980. Glycolytic enzymes from human autoptic brain cortex: Normal and demented cases. Mech. Aging Dev. 14: 203-209.
31. JENDROSKA, K., J. CERVOS-NAVARRO & W. POEWE. 1993. Deposition of beta-amyloid associated with cerebral hypoxia (abstract). Clin. Neuropathol. 12: 252.
32. JENDROSKA, K., W. POEWE, S. E. DANIEL, J. PLUESS, H. IWERSSEN-SCHMIDT, J. PAULSEN, S. BARTHEL, L. SCHELOSKY, J. CERVOS-NAVARRO & S. J. DEARMOND. 1995. Ischemic stress induces depostion of amyloid beta immunoreactivity in human brain. Acta Neuropathol. 90: 461-466.
33. KALARIA, R. N., S. U. BHATTI, W. D. LUST & G. PERRY. 1993. The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion. Ann. N. Y. Acad. Sci. 695: 190-193.
34. KENNEDY, A. M., M. N. ROSSOR & R. S. F. FRACKOWIAK. 1995. Positron emission tomography in familial Alzheimer disease. Alzheimer Dis. Assoc. Dis. 9: 17-20.
35. KHACHATURIAN, Z. S. 1993. Calcium regulation: Final common pathway for age associated neurodegenerative process. Neurosci. Res. Commun. 13: 3-6.
36. KNUSEL, B. & H. GAO. 1996. Neurotrophins and Alzheimer's disease: Beyond the cholinergic neurons: Life Sci. 58: 2019-2027.
37. Koo, E. H., L. PARK & D. J. SELKOE. 1993. Amyloid beta protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. Natl. Acad. Sci. USA 90: 4748-4752.
38. MANN, D. M. A. 1994. Pathological correlation of dementia in Alzheimer's disease. Neurobiol Aging 15: 357-360.
39. MEIER-RUGE, W., C. BERTONI-FREDDARI & P. IWANGOFF. 1994. Changes in brain glucose metabolism as a key to the pathogenesis of Alzheimer's disease. Gerontology 40: 246-252.
40. MEIER-RUGE, W. & C. BERTONI-FREDDARI. 1996. The significance of glucose turnover in the brain in the pathogenetic mechanisms of Alzheimer's disease. Rev. Neurosci. 7: 1-19.
41. MEIER-RUGE, W., O. HUNZIKER & P. IWANGOFF. 1991. Senile dementia: A threshold phenomenon of normal aging? A contribution of the functional reserve hypothesis of the brain. Ann. N. Y. Acad. Sci. 621: 104-118.
42. MEIER-RUGE, W., P. IWANGOFF & C. BERTONI-FREDDARI. 1994. What is primary and what is secondary for amyloid in Alzheimer's disease? Ann. N. Y. Acad. Sci. 719: 230-237.
43. MEIER-RUGE, W. 1990. Senile dementia-a disease of exhaustion of functional brain reserve capacity. Excerpta Med. Curr. Clin. Pract. Ser. 59: 371-375.
44. MENEILLY, G. & A. HILL. 1993. Alterations in glucose metabolism in patients with Alzheimer's disease. J. Am. Geriatr. Soc. 41: 710-714.
45. MIELKE, R., R. SCHRÖDER, G. R. FINK, J. KESSLER, K. HERHOLZ & W. D. HEISS. 1996. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropath. 91: 174-179.
46. MILWARD, E. A., R. PAPADOPOULOS, S. J. FULLER, R. D. MOIR, D. SMALL, K. BEYREUTHER & C. L. MASTERS. 1992. The amyloid protein precursor of the Alzhei- mer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron 9: 129-137.
47. MIQUEL, J. & J. E. FLEMING. 1984. A two-step hypothesis on the mechanisms of in vitro cell aging: Cell differentiation followed by intrinsic mitochondrial mutagenesis. Exp. Geront. 19: 31-36.
48. MIQUEL, J. 1991. An integrated theory of aging as the result of mitochondrial DNA mutation in differentiated cells. Arch. Gerontol. Geriatr. 12: 99-117.
49. MUCKE, L., E. MASLIAH, W. B. JOHNSON, M. D. RUPPE, M. ALFORD, E. M. ROCKENSTEIN, S. FORSS-PETTER, M. PIETROPAOLO, M. MALLORY & C. R. ABRAHAM. 1994. Synaptotrophic effects of human amyloid beta protein precursors of the cortex of transgenic mice. Brain Res. 666: 151-167.
50. NAGLEY, P., J. R. MACKAY, A. BAUMER, R. J. MAXWELL, F. VAILLANT, Z. WANG, C. ZHANG & A. LINNANE. 1992. Mitochondrial DNA mutation associated with aging and degenerative disease. Ann. N. Y. Acad. Sci. 673: 92-102.
51. NIXON, R. A. & M. A. CATALOG. 1994. Free radicals, proteolysis, and the degeneration of neurons in Alzheimer's disease: How essential is the beta-amyloid link? Neurobiol. Aging 15: 463-469.
52. PETTEGREW, J. W., K. PANCHALINGAM, W. E. KLUNK, R. J. MCCLURE & L. R. MUENZ. 1994. Alterations of cerebral metabolism in probable Alzheimer's disease : A preliminary study. Neurobiol. Aging 15: 177-132.
53. PIERT, M., R. A. KOEPPE, B. GIORDANI, S. BERENT & D. E. KÜHL. 1996. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J. Nucl. Med. 37: 201-208.
54. ROBERTS, G. W., S. M. GENTLEMAN, A. LYNCH, L. MURRAY, M. LANDON & D. J. GRAHAM. 1994. Beta amyloid protein deposition in the brain after severe head injury: Implications for the pathogenesis of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatr. 57: 419-425.
55. ROCH, J. M., L. W. JIN, H. NINOMIYA, D. SCHUBERT & T. SAITOH. 1993. Biologically active domain of the secreted form of the amyloid beta/A4 protein precursor. Ann. N. Y. Acad. Sci. 695: 149-157.
56. RODER, H. M., P. A. EDEN & V. M. INGRAM. 1993. Brain protein kinase Pk40 converts tau into a PHF-like form as found in Alzheimer's disease. Biochem. Biophys. Res. Commun. 193: 639-647.
57. RODER, H. M. & V. M. INGRAM. 1991. Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios. J. Neurosci. 11: 3325-3343.
58. SIEGEL, B. V., JR., M. S. BUCHSBAUM, A. STARR, R. C. MOHS & D. C. NETA. 1995. Glucose metabolic rate and progression of illness in Alzheimer's disease. Int. J. Geriatr. Psychiatr. 10: 659-667.
59. SIESJÖ, B. K. & F. BENGTSSON. 1989. Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: A unifying hypothesis. J. Cereb. Blood Flow Metab. 8: 127-140.
60. SISODIA, S. S. 1992. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. USA 89: 6075-6079.
61. SLANSKY, J., K. HERHOLZ, U. PIETRZYK, J. KESSLER, M. GRORID, R. MIELKE & W. D. HEISS. 1995. Cognitive impairment in Alzheimer's disease correlates with ventricular width and atrophy-corrected cortical glucose metabolism. Neuroradiology 37:270-277.
62. SMALL, D. H., V. NURCOMBE, G. REED, H. CLARRIS, R. MOIR, K. BEYREUTHER & C. L. MASTERS. 1994. A heparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neuritric outgrowth. J. Neurosci. 14: 2117-2127.
63. SMALL, D. H., T. WILLIAMSON, G. REED, H. CLARRIS, K. BEYREUTHER, C. L. MASTERS & V. NURCOMBE. 1996. The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease. Ann. N. Y. Acad. Sci. 777: 316-321.
64. SMALL, G. W., J. C. MAZZIOTTA, M. T. COLLINS, L. R. BAXTER, M. F. PHELPS, M. A. MANDELKERN, A. KAPLAN, A. LA RUE, C. F. ADAMSON, L. CHANG, B. H. GUZE, E. H. CORDER, A. M. SAUNDERS, J. L. HAINES, M. A. PERICAK-VANCE & A. D. ROSES. 1995. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer's disease. JAMA 273: 942-947.
65. STEPHENSON, D. T., K. RASH & J. A. CLEMENS. 1992. Amyloid precursor protein accumulates in regions of neurodegeneration following: Focal cerebral ischemia in the rat. Brain Res. 593: 128-235.
66. TANZI, R. E., PH. ST. GEORGE-HYSLOP & J. F. GUSELLA. 1989. Molecular genetic approaches to Alzheimer's disease. TINS 12: 152-158.
67. TOMIMOTO, H., H. WAKITA, J. AKIGUCHI, S. NAKAMURA & J. KIMURA. 1994. Temporal profiles of accumulation of amyloid beta/A4 protein precursor in the gerbil after graded ischemic stress. J. Cereb. Blood Flow Metab. 14: 565-573.
68. TSUJI, K., Y. NAKAMURA, T. OGATA, T. SHIBATA & K. KATAOKA. 1994. Rapid decrease in ATP content without recovery phase during glutamate-induced cell death in cultured spinal neurons. Brain Res. 662: 289-292.
69. WALLACE, D. C. 1992. Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 256: 628-632.
70. WHITSON, J. S., C. G. GLABE, E. SHINTANI, A. ABER & C. W. COTMAN. 1990. Beta-amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110: 319-324.
71. YING W. 1996. Deleterious network hypothesis of Alzheimer's disease. Med. Hypothesis 46: 421-428.